51
|
Hirayama Y, Jeong S, Watanabe Y, Imai N, Ishiyama H, Miyatake H, Oyaizu M, Kim Y, Mukai M, Sonoda T, Wada M, Huyse M, Kudryavtsev Y, Van Duppen P. Present Status of KEK Isotope Separation System. EPJ WEB OF CONFERENCES 2014. [DOI: 10.1051/epjconf/20146611017] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
52
|
Kotzer T, Gascoyne M, Mukai M, Ross J, Waito G, Milton G, Cornett RJ. 36Cl,129I and Noble Gas Isotope Systematics in Groundwaters from the Lac du Bonnet Batholith, Manitoba, Canada. RADIOCHIM ACTA 2013. [DOI: 10.1524/ract.1998.82.special-issue.313] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
53
|
Komori K, Mukai M, Ishitoko C, Sugitani K, Nakata Y, Tei G, Masu Y, Shioyama W, Awata N, Hori M. Relationship Between Hypertension and Proteinuria Associated with Bevacizumab : Retrospective Study on Cardiac Toxicity. Ann Oncol 2013. [DOI: 10.1093/annonc/mdt459.119] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
54
|
Kanda M, Kondo M, Mukai M. AB0182 Glucocorticoid therapy underestimates the disease activity index of rheumatoid arthritis during biologic therapy. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2013-eular.2505] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
55
|
Mukai M, Kanda M, Kondo M. AB0242 The evaluation of methotrexate related lymphoproliferative disease. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2013-eular.2565] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
56
|
Mukai M, Kanda M, Kondo M. AB0183 The evaluation of clinical evaluation for disease activity of rheumatoid arthritis. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2013-eular.2506] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
57
|
Muto M, Kaji T, Mukai M, Nakame K, Yoshioka T, Tanimoto A, Matsufuji H. Ghrelin and glucagon-like peptide-2 increase immediately following massive small bowel resection. Peptides 2013; 43:160-6. [PMID: 23517879 DOI: 10.1016/j.peptides.2013.03.006] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/21/2012] [Revised: 03/01/2013] [Accepted: 03/01/2013] [Indexed: 01/17/2023]
Abstract
Children with short bowel syndrome face life-threatening complications. Therefore, there is an urgent need for a new therapy to induce effective adaptation of the remnant intestine. Adaptation occurs only during feeding. We focused on preprandial acyl ghrelin and des-acyl ghrelin, and postprandial glucagon-like peptide-2 (GLP-2), which are known to have active orexigenic and trophic actions. This study aims to clarify the secretion trends of these hormones after massive small bowel resection and to obtain basic data for developing a new treatment. Sixty-three growing male rats were used: 3 were designated as controls receiving no operation and 60 were randomized into the 80% small bowel resection (80% SBR) group and the transection and re-anastomosis group. Changes in body weight, food intake, and remnant intestine morphology were also assessed for 15 days after the operation. Acyl ghrelin and des-acyl ghrelin levels increased immediately, equivalently in both operation groups (P=0.09 and 0.70). Interestingly, in 80% SBR animals, des-acyl ghrelin peaked on day 1 and acyl ghrelin peaked on day 4 (P=0.0007 and P=0.049 vs controls). GLP-2 secretion was obvious in 80% SBR animals (P=2.25×10(-6)), which increased immediately and peaked on day 4 (P=0.009 vs. controls). Body weight and food intake in 80% SBR animals recovered to preoperative levels on day 4. Morphological adaptations were evident after day 4. Our results may suggest a management strategy to reinforce these physiological hormone secretion patterns in developing a new therapy for short bowel syndrome.
Collapse
|
58
|
Seki H, Hayashida T, Jinno H, Takahashi M, Hirose S, Mukai M, Kitagawa Y. AOSP9 HOXB9, A GENE PROMOTING TUMOUR ANGIOGENESIS AND PROLIFERATION, IS SIGNIFICANTLY ASSOCIATED WITH POOR CLINICAL OUTCOMES IN ER-POSITIVE BREAST CANCER PATIENTS. Eur J Cancer 2013. [DOI: 10.1016/s0959-8049(13)70023-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
59
|
Mukai M, Yokooka Y, Seki M, Okuda Y, Ando Y. Proposal of the Cooperation Method Between EMR/CPOE-RIS-TMS by Using the IHE (integrating the Healthcare Enterprise) - Implementation and Challenge. Int J Radiat Oncol Biol Phys 2012. [DOI: 10.1016/j.ijrobp.2012.07.2252] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
60
|
Shioyama W, Mukai M, Tone E, Harada H, Awata N, Hori M, Arai Y, Nishimura K, Yamazaki T. Severe Cardiotoxicity in a Patient with Renal Cell Carcinoma Treated with MTOR Inhibitor: A case Report. Ann Oncol 2012. [DOI: 10.1016/s0923-7534(20)32477-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
|
61
|
Warner JH, Margine ER, Mukai M, Robertson AW, Giustino F, Kirkland AI. Dislocation-Driven Deformations in Graphene. Science 2012; 337:209-12. [DOI: 10.1126/science.1217529] [Citation(s) in RCA: 304] [Impact Index Per Article: 25.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
|
62
|
Uzal FA, Mukai M, Woods L, Poppenga R, Valentine BA, Smith J. Acute respiratory distress in an alpaca. Vet Pathol 2012; 49:1070-3. [PMID: 22677877 DOI: 10.1177/0300985812447825] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
An alpaca was presented with a history of respiratory difficulty and death. Histology of the phrenic nerves and diaphragm revealed degenerative changes consistent with denervation atrophy, and a diagnosis of diaphragmatic paralysis was established. No gross or histological abnormalities were observed in the spinal cord or other organs. The etiology of the phrenic nerve neuropathy could not be determined. The need to examine phrenic nerves and diaphragm in camelids with respiratory distress is emphasized, as failure to examine these samples will preclude a diagnosis of diaphragmatic paralysis.
Collapse
|
63
|
Mukai M, Okuda Y, Yokooka Y, Seki M, Ando Y, Tsuji H. EP-1484 CONSTRUCTION OF THE COOPERATION BETWEEN THE HIS AND TMS BY USING IHE ESI INTEGRATION PROFILE. Radiother Oncol 2012. [DOI: 10.1016/s0167-8140(12)71817-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
64
|
Mukai M, Sameshima H, Kodama Y, Yamashita R, Kaneko M, Ikenoue T, Matsufuji H, Kondo K, Chijiiwa K. Congenital infantile fibrosarcoma in a very low-birth-weight infant. J Pediatr Surg 2012; 47:e1-4. [PMID: 22498408 DOI: 10.1016/j.jpedsurg.2011.11.052] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/23/2011] [Revised: 11/14/2011] [Accepted: 11/14/2011] [Indexed: 10/28/2022]
Abstract
We describe a prenatally diagnosed case with congenital infantile fibrosarcoma, which is a rare malignant tumor, of which there have been only 14 cases reported in the English literature. A giant mass on the left thigh was detected at 24 weeks' gestation by prenatal ultrasonography. Because of its rapid growth and nonreassuring fetal status in utero, the baby was delivered by cesarean delivery at 27 weeks' gestation. The case was complicated by hemorrhagic anemia, coagulopathy, and cardiac failure, and a tumor resection was performed on day 3. As of age 2.5 years, he was healthy without evidence of recurrence. Because some fetal cases with congenital infantile fibrosarcoma have a poor prognosis, termination of pregnancy at an appropriate time and postnatal early treatment are crucial for successful treatment.
Collapse
|
65
|
Chakraborty P, Chakravarty BN, Kabir SN, Goswami SK, Yenicesu O, Gulerman C, Ozyer S, Cakar E, Sarikaya E, Mollamahmutoglu L, Daponte A, Deligeoroglou E, Pournaras S, Tsezou A, Garas A, Skentou H, Messinis IE, Chakravarty BN, Ganesh A, Chowdhuri K, Shyam T, Ghosh S, Chattopadhyay R, Banerjee P, Pasricha P, Chakravarty BN, Chaudhury K, Kuji N, Kitamura S, Mochimaru Y, Yamada M, Hamatani T, Kawakami M, Hirayama A, Sugimoto M, Soga T, Tomita M, Yoshimura Y, Tabibi A, Tarahhomi M, Roghayee M, Bayatsarmadi H, Zolghadri J, Younesi M, Bug S, Solfrank B, Pricelius J, Craig A, Botcherby M, Stecher M, Bingemann S, Becker B, Nevinny-Stickel-Hinzpeter C, Kuroda K, Venkatakrishnan R, Salker MS, Quenby S, Brosens JJ, Rahmati M, Petitbarat M, Dubanchet S, Chaouat G, Ledee N, van den Berg M, van Maarle MC, van Wely M, Goddijn M, Telli P, Erdem M, Bozkurt N, Oktem M, Yirmibes K. M, Karabacak O, Erdem A, Kim CH, Lee KH, Kim SH, Chae HD, Kang BM, Jung KS, Johnson S, Godbert S, Perry P, Parkinson P, Vink-Ranti CQJ, Van Os HC, Tucker KE, Kapiteijn K, Heijdra PMA, Jansen CAM, Matsumoto H, Sato Y, Suginami K, Horie A, Fujiwara H, Konishi I, Yamada S, Kataoka N, Ogata S, Mukai M, Inai K, Hashimoto H, Tokura Y, Mizusawa Y, Matsumoto Y, Okamoto E, Kokeguchi S, Shiotani M, Mariee N, Li TC, Laird SM, Refaat B, Simpson H, Ledger W, Confino E, Williams A, Grabar V, Feskov A, Feskova I, Blazhko E, Horie A, Fujiwara H, Sato Y, Suginami K, Matsumoto H, Maruyama M, Konishi I, Hattori A, Chi HB, Qiao J, Wang HN, Hong TP, Gao HW, Abdelnaby El Gelany SAA, Nady Abdelmegeed A, Markoff A, Rogenhofer N, Engels L, Bogdanova N, Tuettelmann F, Thaler C, Seckin B, Sarikaya E, Sargin Oruc A, Celen S, Cicek N, Zarei S, Torabi R, Zeraati H, Zarnani AH, Akhondi MM, Hadavi R, Savadi-Shiraz E, Jeddi-Tehrani M, Sugiura-Ogasawara M, Ozaki Y, Katano K, Suzumori N, Kitaori T, Mizutani E, Al-Gubory KH, Bolifraud P, Angele K, Grange S, Puillet-Anselme L, Garrel C. EARLY PREGNANCY. Hum Reprod 2012. [DOI: 10.1093/humrep/27.s2.76] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
66
|
Ingerslev H, Hindkjaer J, Kirkegaard K, Teranishi Y, Ando H, Takayanagi T, Suzuki N, Moroi H, Mukai M, Shen S, Chen AA, Willman SP, Chenette PE, Boostanfar R, Baker VL, Abusief M, Suraj V, Wirka K, Loewke K, Meseguer M, Tejera A, Herrero J, de los Santos M, Viloria T, Remohi J, Gamiz P, Basile N, Munoz M, Marcos J, Requena A, Meseguer M. SESSION 16: EMBRYOLOGY - EMBRYO IN MOTION. Hum Reprod 2012. [DOI: 10.1093/humrep/27.s2.16] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
67
|
Seki H, Hayashida T, Jinno H, Hirose S, Takahashi M, Mukai M, Kitagawa Y. HOXB9, a gene promoting tumor angiogenesis and proliferation, as a prognostic factor in breast cancer. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.27_suppl.33] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
33 Background: We demonstrated that HOXB9, a member of homeobox genes, expression promoted tumor neovascularization and metastasis in vitro and in vivo assay. These findings imply that overexpression of HOXB9 contributes to tumor progression through activation of signaling pathways that alter both tumor-specific cell fates and tumor-stromal microenvironment, leading to increased invasion and metastasis. (Hayashida et al., PNAS 2010) We sought to determine whether these results could be extended to the clinical application. In this study, we evaluated the correlation between HOXB9 expression, clinical outcomes, and the clinicopathological variables in breast cancer patients, and the contribution of HOXB9 expression to tumor cell proliferation and angiogenesis. Methods: A consecutive series of 141 patients with invasive ductal carcinoma who underwent surgical treatment were examined. HOXB9 protein expression was analyzed immunohistochemically using the anti-human HOXB9 polyclonal antibody. Immunostaining of Ki-67, CD31, and CD34 were performed to evaluate the association of proliferation and tumor angiogenesis with HOXB9 expression. Results: Of 141 tumor specimens immunostained for HOXB9, 69 specimens (48.9%) were positive staining. Univariate logistic regression revealed ER and PgR negativity, HER2 positivity, high nuclear grade, and large pathological tumor size as significant variables associated with HOXB9 expression. Moreover, 12 (92.3%) out of 13 triple negative breast cancer showed HOXB9 expression. The disease-free survival (DFS) and the overall survival were significantly different between the HOXB9 positive and negative group; HR=20.714, p=0.001, HR 9.206, p=0.003, respectively. A Multivariate analysis indicated that HOXB9 expression was the only independent prognostic factor for DFS (HR=15.532, p=0.009). In subgroup analysis, HOXB9 positive tumors showed a significant increase in the number of vasculature and the Ki-67 ratio in comparison with HOXB9 negative. Conclusions: Our results suggest that HOXB9 expression promoting the tumor proliferation and the angiogenesis is a significant prognostic factor in breast cancer.
Collapse
|
68
|
Takahashi M, Jinno H, Hayashida T, Hirose S, Mukai M, Kitagawa Y. Prognosis and non-sentinel lymph node status of the breast cancer patients with micrometastatic sentinel lymph nodes. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.27_suppl.140] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
140 Background: Sentinel lymph node biopsy (SLNB) is a more sensitive and accurate nodal staging procedure than axillary lymph node dissection (ALND). Because of detailed pathologic evaluation in SLNs, more nodal micrometastases have been identified. However, it remains controversial whether to perform ALND for patients with micrometastases in SLNs and their prognostic significance is also a matter of debate. The purpose of this study is to determine the non-sentinel lymph node (NSLN) status and prognosis of the patients with micrometastatic SLNs. Methods: A prospective database of 1,012 clinically node-negative, T1-T2 breast cancer patients, who underwent SLNB from January 2002 to Dec 2010 at Keio University Hospital was analyzed. SLNs were detected using a combined method of isosulfun blue dye and small-sized technetium-99m-labeled tin colloid. Intraoperative frozen examination was performed with hematoxylin and eosin (HE) staining. SLNs, fixed and embedded in paraffin, were additionally diagnosed with HE staining and immunohistochemical (IHC) analysis. Results: Micrometastases in SLNs were found in 69 (6.8%) of 1,012 patients. Thirty eight (55.1%) of 69 patients with micrometastatic SLNs underwent immediate or delayed ALND and revealed no NSLN metastasis. Among 31 (44.9%) patients with micrometastatic SLNs who omitted ALND and axillary radiation therapy, no axillary lymph node recurrence has been observed after a median follow-up of 50 months, although 29 patients (93.5%) in these 31 patients received adjuvant systemic therapy. There is no significant difference in recurrence free survival between the patients with micrometastatic and negative SLNs (98.0% vs. 95.7%, respectively). Conclusions: These date suggested that it may not be necessary to perform ALND for the patients with micrometastatic SLNs and the presence of micrometastases in SLNs may not worsen prognosis with proper systemic therapy.
Collapse
|
69
|
Ichikawa R, Hosoe N, Imaeda H, Takabayashi K, Bessho R, Ida Y, Naganuma M, Hisamatsu T, Inoue N, Kanai T, Iwao Y, Mukai M, Hibi T, Ogata H. Evaluation of small-intestinal abnormalities in adult patients with Henoch-Schönlein purpura using video capsule. Endoscopy 2011; 43 Suppl 2 UCTN:E162-3. [PMID: 21563063 DOI: 10.1055/s-0030-1256266] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/10/2022]
|
70
|
Shimosawa H, Matsumoto M, Yabe H, Mukai M, Toyama Y, Morioka H. Primary primitive neuroectodermal tumor of the conus medullaris in an elderly patient: a case report and review of the literature. Case Rep Oncol 2011; 4:267-74. [PMID: 21734881 PMCID: PMC3124460 DOI: 10.1159/000323263] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
Abstract
Primary spinal primitive neuroectodermal tumors (PNETs) are very rare conditions. Most of these tumors occur in children and young adults. A 63-year-old man with a primary spinal PNET in the conus medullaris from the L1 to L2 level is presented in this report. The optimal treatment of primary spinal PNETs is yet unknown. Surgical resection, radiation therapy, and chemotherapy have been advocated for the treatment of spinal PNET based on PNETs at other sites. However, the outcome is very poor. There are a few reports of cases with long-term survival and no recurrence. In these patients, en bloc resections were performed.
Collapse
|
71
|
Takahashi M, Jinno H, Hayashida T, Sakata M, Hirose S, Mukai M, Kitagawa Y. Prognosis and nonsentinel lymph node status of the patients with breast cancer with micrometastatic sentinel lymph nodes. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.e11503] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
72
|
Hayashida T, Jinno H, Seki H, Takahashi M, Sakata M, Hirose S, Mukai M, Kitagawa Y. The relationship of HOXB9 expression promoting tumor cell proliferation and angiogenesis to clinical outcomes of patients with breast cancer. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.10546] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
73
|
Takahashi M, Jinno H, Hayashida T, Sakata M, Mukai M, Kitagawa Y. P242 Accuracy of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer patients. Breast 2011. [DOI: 10.1016/s0960-9776(11)70188-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
74
|
Jinno H, Matsuda S, Sakata M, Hayashida T, Takahashi M, Hirose S, Mukai M, Ikeda T, Kitagawa Y. P184 Differential pathologic response from primary systemic chemotherapy across breast cancer intrinsic subtypes. Breast 2011. [DOI: 10.1016/s0960-9776(11)70126-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
75
|
Takahashi M, Hayashida T, Sakata M, Mukai M, Kitagawa Y, Jinno H. The Feasibility Of Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy For Breast Cancer Patients. J Surg Res 2011. [DOI: 10.1016/j.jss.2010.11.431] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|